Jun Qi Lab

Chemical Biology lab @HarvardMed and @DanaFarber. We use a multidisciplinary approach to study biological roles of epigenetic proteins & transcription factors.

[Jun Qi Lab @JunQiLab]

@10mM_Mike what a journey. Congratulations!

[Jun Qi Lab @JunQiLab]

Our collaborative work with @IrenemGhobrial on targeting transcription factor IRF4 is now online @nchembio. It is so exciting that we discovered an IRF4 binder & a selective IRF4 degrader that can interrupt MM cell growth. Congrats @10mM_Mike & all authors https://t.co/RJFu6wqJsU

[Jun Qi Lab @JunQiLab]

@sciqst @MolMetab Yes, with the multiple targets and pathways we identified, they are all can be targets for novel therapy development.

[Jun Qi Lab @JunQiLab]

Our collaborative study with Dr. Qiong Duan on histone acetylation regulated energy storage is now published @MolMetab. We established more understanding on how "active" acetylation vs "passive" acetylation balanced each other at different states. https://t.co/p7c8jju8vw

[Jun Qi Lab @JunQiLab]

Thank you @StBaldricks for highlight our research on studying natural compound in DMG with Prof. Movassaghi @ChemistryMIT and @FilbinMariella. Thank you so much for your support @StBaldricks

[St. Baldrick's Foundation @StBaldricks]

Hope is powerful. Research is lifesaving. 🙏

Your support helps fund groundbreaking discoveries for children battling cancer.

Read how it’s making a difference in our latest edition of Research Outcomes: https://t.co/1ZhjvSdu8A

[Jun Qi Lab @JunQiLab]

With better understanding of proteosome machinery, hopefully, we can come up more and more cool idea to utilize the system for novel therapy development.

[Dana-Farber News @DanaFarberNews]

New research in @angew_chem by @DanaFarber’s @JunQiLab reveals a novel chemical biology approach to achieving selective targeted protein degradation using proteosome cap region proteins directly in addition to the current PROTAC strategy, which could aid in developing therapies and cancer drugs.

➡️ https://t.co/yoRfR5X0Tv

[Jun Qi Lab @JunQiLab]

It was such a fun day to visit ⁦@PennMedicine⁩ and talk about science with ⁦@junwei_s⁩ ⁦@LilingWanLab⁩ and present our science. Thank you for having me.

[Jun Qi Lab @JunQiLab]

Our work using cap region proteins of proteosome to directly induce targeted protein degradation is now published online @angew_chem. Congratulations to all the authors on bringing this to the finish line. Thanks @BloodCancerUtd for supporting our work.
https://t.co/wy8BZ5wRWv

[Jun Qi Lab @JunQiLab]

We would like to thank the support from @EpendymomaRF, @curingkidsckc and @StBaldricks that allow us to build our biology capability to explore novel therapeutic options for pediatric brain cancer.

[Jun Qi Lab @JunQiLab]

Our collaborative work with Prof. Mo Movassaghi at @chemistryMIT and @FilbinMariella is now online @acsJACS @ACSPublications. Thrilled to work as chemical biology part to explore therapeutic potential of these awesome nature compounds from Mo's lab. https://t.co/xSz7D7tTAW

[Jun Qi Lab @JunQiLab]

I am thrilled to work and publish together with my postdoc PI, Prof. Mo Movassaghi @ChemistryMIT to bring their sophisticated chemistry to potential therapy development. I am excited to keep learning from Mo and @FilbinMariella. Pic from: https://t.co/rFGOAqxkBE

[Jun Qi Lab @JunQiLab]

Our collaborative work with Prof. Mo Movassaghi at @chemistryMIT and @FilbinMariella is now online @acsJACS @ACSPublications. Thrilled to work as chemical biology part to explore therapeutic potential of these awesome nature compounds from Mo's lab. https://t.co/xSz7D7tTAW

[Jun Qi Lab @JunQiLab]

This is absolutely fun!!! @LabSethi cannot wait to do more together. To create more and better understanding in cancers and find potential novel therapy together. @AGA_Gastro

[Sethi_Lab @LabSethi]

Can we have a biotinylated and inactive version of the HDAC1/2 inhibitor? How do you do Chem-seq, Jun? In the end, we were able to follow our observations and publish these findings thanks to collaborative science fostered by @DanaFarber @DanaFarberNews

[Jun Qi Lab @JunQiLab]

It is so exciting to see the final version of our collaborative work with @LabSethi. We found that blocking HDAC1/2 pushes CRC cells out of a stem-like state and into differentiation. We will work tother more to find novel therapeutic options for CRC. https://t.co/VGfazP6PeG

[Jun Qi Lab @JunQiLab]

@rosslevinemd congratulations. such a well-deserved recognition!!!!

[Jun Qi Lab @JunQiLab]

@LabSethi it is a true pleasure to work with you and your team.

[Jun Qi Lab @JunQiLab]

It is so exciting to see our collaborative work with @Nilay_Sethi is now available online. My team and I are always eager to learn more about novel therapy development for CRC together with Nilay and his wonderful team!!!

[Dana-Farber News @DanaFarberNews]

Proof-of-concept: Epigenetic reprogramming could one day be a new therapeutic path in colorectal cancer. @Nilay_Sethi explains how histone acetylation shapes CRC cell fate in this @AGA_Gastro study: https://t.co/ZQpe45nYb4

[Jun Qi Lab @JunQiLab]

@FilbinMariella @DFBC_PedCare @DanaFarber @broadinstitute Great group of scientists with a great leader!!!!

[Jun Qi Lab @JunQiLab]

@Tamer_Onder Nice picture

[Jun Qi Lab @JunQiLab]

It is awesome to have JQ-WON team to build a boat and get first place in the boat building competition at ⁦@DFCI_ChemBio⁩ retreat!!!! Awesome design, decoration, ride, and teamwork!

[Jun Qi Lab @JunQiLab]

It is so great to have @LilingWanLab to visit us and give a great seminar.

[Liling Wan @LilingWanLab]

Had a great time visiting Dana-Farber Cancer Institute and sharing our work on chromatin mechanisms in cancer! Huge thanks to @JunQiLab for the invitation and generous hosting. So much fun reconnecting with mentor & old friends, making new ones, & a full day of amazing science!